Manufacturers/Nephron Pharmaceuticals Corporation

Nephron Pharmaceuticals Corporation

24 drugs in NADAC|23 Generic,1 Brand

View Recalls (6)

Total Drugs

23G / 1B

Avg Price / Unit

$0.2622

$0.03 – $0.75

Avg 7d Change

+0.52%

Across 19 drugs with changes

7d Activity

10↑9↓5 flat

of 24 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

24 drugs total, 24 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
ASTHMANEFRIN RFILL 2.25% SOLN racepinephrine hydrochloride	00487278401	$0.7541 per EA	—	Brand OTC	—	—
BUDESONIDE 0.25 MG/2 ML SUSP BUDESONIDE	00487960101	$0.7511 per ML	+0.12%	Generic	—	Corticosteroid
BUDESONIDE 0.25 MG/2 ML SUSP BUDESONIDE	00487960130	$0.7511 per ML	+0.12%	Generic	—	Corticosteroid
BUDESONIDE 0.5 MG/2 ML SUSP BUDESONIDE	00487970130	$0.7068 per ML	-1.82%	Generic	—	Corticosteroid
BUDESONIDE 0.5 MG/2 ML SUSP BUDESONIDE	00487970101	$0.7068 per ML	-1.82%	Generic	—	Corticosteroid
ALBUTEROL 2.5 MG/0.5 ML SOL Albuterol Sulfate	00487990130	$0.5001 per EA	-0.90%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL 2.5 MG/0.5 ML SOL Albuterol Sulfate	00487990102	$0.3616 per EA	—	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 0.63 MG/3 ML SOL Albuterol Sulfate	00487030101	$0.2512 per ML	-2.02%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 1.25 MG/3 ML SOL Albuterol Sulfate	00487990401	$0.2230 per ML	-0.38%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 1.25 MG/3 ML SOL Albuterol Sulfate	00487990425	$0.1854 per ML	-2.27%	Generic	—	beta2-Adrenergic Agonist
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980160	$0.1104 per ML	+3.69%	Generic	—	Anticholinergic
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980130	$0.1084 per ML	+2.68%	Generic	—	Anticholinergic
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980101	$0.1084 per ML	+2.68%	Generic	—	Anticholinergic
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980125	$0.1057 per ML	+6.65%	Generic	—	Anticholinergic
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020101	$0.0877 per ML	-1.12%	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020103	$0.0877 per ML	-1.12%	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020160	$0.0839 per ML	-0.70%	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020102	$0.0723 per ML	—	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950101	$0.0658 per ML	+0.64%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950103	$0.0658 per ML	+0.64%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950160	$0.0658 per ML	+3.64%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950125	$0.0606 per ML	+1.17%	Generic	—	beta2-Adrenergic Agonist
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980102	$0.0529 per ML	—	Generic	—	Anticholinergic
SODIUM CHLORIDE 0.9% SOLUTION Sodium Chloride	00487430110	$0.0262 per ML	—	Generic	—	—

FDA Recalls (6)

Recalls matched by company name. Verify current status with FDA.

D-0154-2020 →

Terminated

Class III

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Incorrect labeling: Incorrect or missing lot and/or exp date

Initiated: 10/21/2019

D-0150-2020 →

Terminated

Class II

Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10

Lack of Assurance of Sterility; bags have potential to leak

Initiated: 10/9/2019

D-0148-2020 →

Terminated

Class II

PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25

GMP Deviations: potential glass contamination

Initiated: 10/9/2019

D-0147-2020 →

Terminated

Class II

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25

GMP Deviations: potential glass contamination

Initiated: 10/9/2019

D-0151-2020 →

Terminated

Class II

del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-984-10

Lack of Assurance of Sterility; bags have potential to leak

Initiated: 10/9/2019

D-0149-2020 →

Terminated

Class II

PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-526-20

GMP Deviations: potential glass contamination

Initiated: 10/9/2019